David Masó

David Masó

Co-Founder & CEO Avatia
David Masó
Pharma is about to change with AI co-workers. Fundamentally. A new era of human-AI collaboration in healthcare is coming. Not as a feature. As infrastructure. After +15 years of experience in Pharma Tech, I'm co-founding a company to augment the people inside pharma and unlock a level of scale and intelligence the industry has never seen. My purpose is simple but very challenging: Helping every person get the right therapy at the right time. We believe patients and customers shouldn't have to wait for medicines or treatments that already exist. What increasingly limits impact isn't the science, but how well commercial teams can reach and serve healthcare professionals at scale. I'm building Avatia as the commercial intelligence operating layer to close this gap.

Day 1 | 20th October

5:05 PM Dragons’ Den: Innovators rewriting the rules of pharma engagement through AI

In this dynamic session, hear from pioneering startup CEOs as they share how disruptive AI innovations can transform HCP engagement, offering a forward-looking perspective on what pharma must adopt, adapt or risk falling behind.

Join our Dragons as they assess the latest innovations from startups pitching their tech in a bid to win first place.

Listen up as the Dragons review the benefits of each technology to your business, predict their future successes and deliver their verdicts.

The ultimate decision is in your hands though, as the audience get to vote for their favourite! 

Check out the incredible speaker line-up to see who will be joining David.

Download The Latest Agenda